Flubromazolam is a novel manufactured depressant substance of the benzodiazepine class which produces anxiolytic, disinhibiting, muscle relaxant, and memory smothering impacts when controlled. It is extraordinarily strong (dynamic in the microgram go) with an uncommonly long 18 hour length. 

Flubromazolam has been noted for its potential use in the fleeting treatment of nervousness, sleep deprivation, intense seizures, and the sedation of hospitalized patients. However, it is right now only sold by online research compound merchants for use as a recreational psychoactive substance and has not been formally considered. 

Any remarks in regards to its pharmacology are absolutely hypothesis in view of the subjective impacts it instigates and its auxiliary similitude to triazolam, pyrazolam and different benzodiazepines. 

It is significant that the sudden cessation of benzodiazepines can be conceivably hazardous or dangerous for people utilizing frequently for broadened timeframes, once in a while bringing about seizures or passing. It is very prescribed to decrease one's measurements by continuously bringing down the sum taken every day for a delayed timeframe as opposed to ceasing suddenly. 

Flubromazolam is a concoction of the benzodiazepine class. Flubromazolam is named for the fluorine, bromine, and triazole substitutions on its center benzodiazepine skeleton (FLUorine-BROMine-AZOLe-AM). Flubromazolam is an individual from the benzodiazepine class as it contains a 1,4 diazepine ring melded to a substituted benzene ring. Bromine is bound to this bicyclic structure at R7. Moreover, a fluorine substituted phenyl ring is bound to this structure at R5. 

Flubromazolam likewise contains a methylated triazole ring melded to and fusing R1 and R2 of its diazepine ring. Flubromazolam has a place with a class of benzodiazepines containing this intertwined triazole ring, called triazolobenzodiazepines, recognized by the postfix "- zolam". 

This product is intended for research and forensic applications. Warning - this product is not for human or veterinary use.


Benzodiazepines create an assortment of impacts by official to the benzodiazepine receptor site and amplifying the proficiency and impacts of the neurotransmitter gamma aminobutyric corrosive (GABA) by following up on its receptors. As this site is the most productive inhibitory receptor set inside the cerebrum, its balance brings about the quieting (or quieting impacts) of flubromazepam on the sensory system. 

The anticonvulsant properties of benzodiazepines might be, to a limited extent or totally, because of official to voltage-subordinate sodium channels as opposed to benzodiazepine receptors

This product is intended for research and forensic applications. Warning - this product is not for human or veterinary use.


Flubromazolam is another depressant research concoction having a place with the benzodiazepine class. A psychoactive substance, Fluclotizolam is available in 0.5mg blotter form. Its effects include hypnotic, sedative, and anticonvulsant attributes, and it is available for use by scientists interested in the pharmacology of benzodiazepines. Flubromazolam is likewise additionally an individual from group of dissociative sedatives. So Flubromazolam shares numerous concoction properties like Diazepam or Alprazolam. Flubromazolam is currenctly getting a charge out of much consideration from the worldwide global research network.

Trivial name: Flubromazolam
IUPAC: 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a]
CAS: 612526-40-6
Purity: ≥98%
Molecular weight: 235.28 g·mol−1

Legal status:
Sweden: Flubromazolam has been classified as an illegal substance in Sweden after seizures by customs and police, as well as indications from the EMCDDA of wider use as a recreational drug.

Switzerland: Flubromazolam is illegal in Switzerland as of December 2015.

United Kingdom: In the UK, flubromazolam has been classified as a Class C drug by the May 2017 amendment to The Misuse of Drugs Act 1971 along with several other designer benzodiazepine drugs.

Comments: 0
No comments
Leave a Reply

Your email address cannot be published. Required fields are marked*